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SPECIFIC RELATIONSHIP OF CELL COM
POSJTION TO BIOLOGICAL ACTIVITY
OF HEMOLYTIC STREPTOCOCCP
REBECCA C. LANCEFIELD
Associate, The Rockefeller Institute for Medical Research

early descriptions of streptococci dealt chiefly with their
THEmorphology
and pathogenicity, from the time when Pasteur

(98) saw them as a chain of beads in the blood of a patient dying
of puerperal sepsis until Schottmiiller (107), in 1903, showed
that various streptococci differ in their effect on blood. He dis
tinguished hemolytic streptococci from· Streptococcus viridans,
according to whether the microorganisms hemolyzed or produced
a greenish discoloration of the red blood cells around a colony
growing on a blood agar plate. · Mandelbaum (88), in 1907, de
scribed Streptococcus saprophyticus, now commonly called the
indifferent streptococcus, which did not produce any visible effect
on red blood cells. These observations have been the basis for
the main differentiation of streptococci for almost forty years.
In 1919, Brown (11, 119) defined these three varieties more ex
actly and designated them as alpha, indicating the slightly hemo
lytic, methemoglobin producing strains; beta, those that were
markedly hemolytic; and gamma, those without visible effect on
blood.
Thus, the so-called streptolysin (6) is the cellular component
of hemolytic streptococci that was first useful for classification.
Opinions of the earlier investigators varied with regard to the
filtrability and antigenicity of this substance, but all were unani
mous as to its !ability. McLeod (91) agreed with some of these
investigators in concluding that streptolysin was not antigenic.
He established as a criterion for the production of a soluble
hemolysin, the lysis of washed red blood cells by broth cultures
or their filtrates. This led to some confusion in the case of those
streptococci which hemolyzed whole sections of blood agar plates,
1 Lecture delivered May 15, 1941.
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but failed to yield a "soluble hemolysin" when tested by
McLeod's method (21, 12�, 135). Neill and Mallory (95) found
that, like the lysins of other microorganisms which . they . had
studied, streptolysin was subject to reversible oxidation and
reduction.
Todd, beginning in 1928 (128), reinvestigated.this whole ques
tion and, in 1938 (130-132), offered a more complete explanation
of the peculiarities of the lytic activities of hemolytic strepto
cocci. Briefly, he found two streptolysins, streptolysin O and
streptolysin S, with radically different prop�rties. Mixtures con
taining different proportions of the two explained the variable
results of earlier work. Streptolysin 0, found in serum-free
broth culture filtrates, is subject to reversible oxidation and re
duction. It is antigenic and combines with antibody either in
the oxidized or reduced state, but is hemolytic only when reduced.
.Antibodies to this streptolysin are formed in response to strepto
coccal infections, and serve, therefore, in the study of. human
diseases, as a useful diagnostic index of previous streptococcal
infection. Smythe and Harris (120) concluded from chemical
studies. of partially purified preparations that streptolysin O is
probably protein in nature and that it contains rather large
amounts of sulphur, part of which exists as an -SH� -S-S
oxidation-reduction system. If the -SH groups are removed by
oxidation or other means, the substance becomes hemolytically
inactive.
Todd (131) also investigated the hemotoxin described orig
inally by Weld (138, 139) and distinguished a second highly
toxic substance, streptolysin S, jn filtrates of serum broth cul
tures and in serum extracts of streptococci prepared according
to Weld's technique. These preparations contaii:i much .more
streptolysin S than streptolysin 0, but all preparations also con
tain some streptolysin 0. Todd showed that streptolysin S
probably represents the most active principle of the hemotoxin
described by Weld. In contrast to the oxygen-labile streptol.ysin
0, streptolysin Sis not apparently affected by oxidation or reduc
tion, but is exceedingly labile to acid, and so sensitive to heat that
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it is irreversibly inactivated by .storage even at ordinary ice-box
temperatures, and can be preserved only at -73 ° C. Weld
showf!d that extracts containing this substance are highly toxic
for'mice; and both Weld and Hare (47) studied the pathological
effects in animals, but were unable to correlate the lethal and
hemolytic titers of extracts. Todd (130), however, explained
this discrepancy when he found both streptolysin O and strepto
lysin S in these extracts, and showed that these substances pro
duced distinct pathological effects on mice (3)·. Todd found also
that an'tibodies directed against streptolysin s· are formed in
experimental animals only in response to immunization with liv
ing streptococci. The antibody titers in immunized animals, and
also ·in man following known streptococcal infections, are never
very high but show, nevertheless, a significant increase. In
rheumatic fever patients, Todd, Coburn and Hill (133) con
cluded, from statistical analysis of the results of serological
studies, that the antistreptolysin S titers of rheumatic children
decreased during acute attacks and increased during recovery,
in contrast to the steady rise in titer observed in non-rheumatic
children in response to streptococcal infections or in rheumatic
children who escaped recrudescences following streptococcal in
fections. The low antistreptolysin S titers are also contrasted
with the generally high level of antistreptolysin O during the
acute phase of rheumatic fever.
Although hemolytic activities were the foundation of the first
· successful classifi.cation of streptococci, the results of the action
of the carbohydrate-splitting enzymes of these microorganisms
were often employed in early studies for purposes of classifica
tion. Many investigators sought orderly arrangements of strep
tococci by studying their fermentation reactions, by investigating
the limiting pH values for growth and viability, and by deter
mining other biochemical and cultural' characteristics. Although
considerable progress was possible by these methods, there was
always overlapping among the classes differentiated and the
results were often difficult or impossible to interpret.
Serological classification of hemolytic streptococci was also
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attempted early, using the agglutination reaction and the tech
nique of agglutinin absorption. There are, however, many tech
nical difficulties in. streptococcus agglutination reactions and, by·
the beginning of the last war, opinion was divided as to the value
and meaning of these results, either for the determination of
serologically distinct types or for the differentiation of strains
from human and animal sources (37). It was, however, finally
established, from study of epidemic strains in Army camps in
1918, that specific serological types existed among hemolytic
streptococci paJhogenic for man (25).
GROUP PHENOMENA

Several years later, Hitchcock (59) found that, irrespective of
the type-relationships, hemolytic streptococci isolated from a
wide variety of human diseases all possessed in common a sero
logically active polysaccharide. This, at the time, .seemed con
fusing .because Heidelberger and Avery (54) had just shown that
bacterial polysaccharides were responsible for type-specificity of
pneumococci. The demonstration was so clear for pneumococci,
TABLE I
Most Characteristic Source

Group A

"
"
"

"
"
"
"
"
"
"

Man

B

Bovine mastitis

C

Most !!treptococcal animal diseases

D

Originally identified as cheese strains; also enterococci and other human' saprophytes

E

Normal milk.

F
G
H
K

''Minute''
Large and ''minute''

�}

}

Human nasopharynx
usually non-pathogenic

Chiefly dogs, recently identified by Fry*

• Unpublished data; personal communication.
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that the same principles were thought to apply to other bacteria.
For Streptococcus viridar,,s (60, 71), this proved true, but hemo
lytic f?treptococci offered the first exception to this rule.
The polysaccharide characteristic of hemolytic streptococci
comprising a large number of strains pathogenic for man, now
designated as Group A_, reacted· specifically with the serum of
animals immunized with any other members of this group. How
ever, a series of strains isolated from lower animals failed to give
this reaction, and it was thought, therefore, that other groups of·
streptococci might also be characterized by carbohydrates specific
for each group. This, indeed, proved true, and several addi
tional groups have been identified as shown in Table I, in which.
eleven groups are designated with their most characteristic
sources. Group A is composed of strains usually pathogenic for·
man; Group B, of those from bovine mastitis; Group C is found.
in a great many streptococcal diseases of lower animals; Group,
D, originally identified in strains isolated from cheese, also in-
eludes the so-called enterococci and other human saprophytes;·
Group E is found in normal milk; Groups; F to K occur in the,
human nasopharynx, usuaJly not associated with disease; and
Groups L and M have been recently designated by Fry, and.
include streptococci found so far chiefly in- diseases of dogs.
Members of most of the known groups· have, however, been.
obtained in cultures from various parts of the human body. In.
Table II are listed the groups, members of which have been iso
lated from man and from other animal&. The chief pathogenic, ·
streptococci of human, bovine or equine origin are fairly well
known: Group A, in man, Groups B and C in cattle, Group C ·in
horses. Among guinea pigs also, Group C streptococci are
known to be the chief pathogens, as well as among most other·
doD?-estic and laboratory animals, with the possible exceptions of
the monkey, the mouse, and the dog. The second column shows.
the usual distribution of serological groups of hemolytic strepto-
cocci in respect to disease in different animals. Occasionally,
however, members of groups not usually pathogenic for a species.
are isolated from undoubted infections, as shown in the third

256

. REBECCA C. LANCEFIELD
TABLE II

Pathogenicity of.Serological Groups of Hemolytic Btreptoooooi ·

-

Animal
source
?,fan

Cattle

,

•

Horse
Monkey
Dog

Chicken
Swine
Goat
Sheep
Fox
Ferret
Rabbit
Guinea Pig

Mouse

Chief
pathogenie
groups

Occasionally
pathogenic
groups

Groups
found but
apparently
non-pathogenie

References

A

B, C,D, F,G, H, K,L

15, 18, 32, 44, 46,
48, 51, 52, 63,
77, 82, 105, 106,
111

B,C

A,G

28, 29, 44, 45, 85,
92, 94, 97, 100,
121, 123, 124

D,E,H,L

C

G, L, M

�c

5, 26, 27, 28, 29,
97

A,G

C

At
E,*L

G

C

10, 82, 105, 110
53, 82, 101
28, 29, 100

M
A,B

77

A,B,C

86

* Strains received from Dr. Stafseth.

column ; still others have been found which have never been iso
lated from disease (Column 4). ·More work is necessary before
closer correlations can be established between serological groups
and species susceptibility.
Fatal Human Infections. Investigation of the streptococcal
carrier rate in any community is aided by the possibility of deter
mining easily and accurately whether given strains are likely to
be pathogenic for man, i.e., those. belonging to Group A. It is
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of interest to note the distribution of groups which, although
. they are not usually associated with human disease, may occa
sionally give rise to infection i,n man, even sometimes proving
fatal. The records found in the literature of thirty-eight fatal
human infections due to streptococci of groups other than A are
shown in Table III. Compared with the incidence of fatal Group
TABLE III
Fatal Human Infections: Groups B to K
Group

Diagnosis

B

Puerperal Sepsis
Endocarditis
Terminal
pyelonephritis
Terminal diabetes
Meningitis
Pneumonia

Number

Remarks

References

14
2

Dr. J. H. Brown also
reported 45 strains
isolated from 2,000
autopsies. He considered few of etiological significance.

13, 20, 36, 56,
105, 106,
117

2

Non-hemolytic

112

1
1
6

Hemolytic
Hemolytic
Non-hemolytic
(numerous ·others
in literature)

31, 89, 96, 105

1
1
1
1

20

D

Endocarditis

Proba- Ludwig's angina
bly
Endocarditis
D
Endocarditis

8

1

F

Pansinusitis
· Pneumonia with
empyema

1

G

Puerperal Sepsis
Agranulocytosis
Endocarditis

4
1
1

Etiological relationship uncertain
(with S. aure'U8 in 1
case)

8

19, 90,105,
117

6

A infections, these are relatively few; and usually the strepto
cocci in these cases have been opportunistic or terminal invaders,
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as in puerperal sepsis, endocarditis, pyelonephritis, and agranu
locytosis. There have also been a few cases of primary infection.
Seven ,cultures from twenty fatal cases due to· Group B have
been identified in our laboratory, and the remaining thirteen
have been reported elsewhere, in the literature. In addition to
these, Dr. J. H. Brown isolated from 2,000 autopsies at the Johns
Hopkins Hospital, forty-five Group B strains, a few of which
might possibly have been the primary agent, although most of
them he considered of no etiological significance. No record has
been found of a fatal human infection due to Group C, although
relatively mild puerperal infections and infections of the throat
and urinary tract do sometimes occur. Group C has also been
reported as isolated from erysipelas, but its etiological impor
tance here would apear questionable ( 63). The fatal infections
in Group D are interesting because they were apparently all due
to the so-called enterococcus and were caused either by hemolytic
or by non-hemolytic strains. A few deaths due to G-roups F and
G are also recorded. No records have b�en ·found of fatal human
infections caused by members of any of the other known groups.
Non-hemolytic Members of the Various Serological Groups.
The correlation between hemolytic capacity and serological
grouping is less strict than at first supposed. The serological
groups described were originally confined to hemolytic strepto�
cocci, but it soon became evident that non-hemolytic strains with
apparently identical serological characters were common in
Group B. About half of the bovine strains studied by Stable
forth (.121) were non-hemolytic, although there was no detect
able immunological difference between the hemolytic and non
hemolytic members of this group. He suggested that the pro
duction of hemolysin might be a variable function. One such
variation, indeed, occurred in our own experience (79). The
parent strain was of known serological type and was highly viru
lent for mice. Consequently, it was possible to show by immuno
logical studies that the variant, while maintaining its virulence
and antigenic properties, lost only its capacity to hemolyze red
blood cells and form pigment; and these properties have never
reappeared.
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.As serological investigations of streptococci have been ex
tended, non-hemolytic strains have been found with more or
less frequency among most of the known groups. Completely
non-hemolytic members of Group .A are rare. Todd (127)
studied the transformation of hemolytic Group A strains into
methemoglobin producing variants by passage through mice, and
Fry (35) noted green-producing variants which were of the
same serological type as hemolytic strains isolated from the same
patient. . These strains were normally hemolytic, if grown
anaerobically
.Alpha, or methemoglobin producing, streptococci from bovine
mastitis were found by Little (85) to be members of Group C.
These non-hemolytic strains constitute a group already well-rec
ognized by the physiological studies of S. J. Edwards (30). Cul
turally similar, Group C streptococci have also been isolated very
recently in England as the etiological agent in several outbreaks
of joint-ill in lambs (7) and all belong to a single serological type.
In Group D, non-hemoyltic varieties have been well-studied
by Sherman and his associates (111, 112, 116) and by Graham
and Bartley (39, 61). The non-hemolytic species, S. fecalis and
S. liquefaciens, not only react as members of Group D, but cer
tain strains belong to the same serological types as hemolytic
members of Group D classified biochemically as S. zymogenes.
These authors are agreed on the close antigenic relationship of
hemolytic and non-hemolytic strains of Group D.
Several investigators have found that Group D streptococci
vary in their ability to hemolyze red cells from different species
of animals. Thus, some strains are non-hemolytic on sheep or
goat blood agar, but actively hemolyze red cells from the rabbit
and from several other animal species (67). The explanation of
this phenomenon -is not known.
In other groups, certain non-hemolytic or doubtfully hemolytic
strains are sometimes encountered, particularly in Groups H
and K.
One serological group, composed entirely of non-hemolytic
streptococci, S. lactis, has. been described by Sherman and his
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associates (114). The immunological reactions of S. lactis sepa
ra�e it clearly from S1 fecalis {belonging to Group D), which is
in agreement with other biological reactions of these streptococci
.previously studied by Sherman (115).
The finding of close serological relationship between hemolytic
and non-hemolytic streptococci in no way invalidates the useful
ness of blood. agar as a differential medium in studying these bac
teria. This is especially true 'in Group A. whei;-e few, if any,
frankly non-hemolytic strains are known. The knowledge that
both non-hemolytic and actively hemolytic streptococci may be
long to th.e same serological groups directs attention to the fact
that they have other fundamental physiological characters in
common, which were in some cases overlooked previously on ac
count of the special emphasis placed on the single property of
elaborating extracellular hemolysins.
As· an illustration, one might cite the recognized insuscepti
bility of Group D hemolytic streptococci to the action of sul
fonamides. With this knowledge, one would question the value
of sulfonamide therapy of patients infected with non-hemolytic
strains of Group D, members of which are occasionally isolated
from cases of subacute bacterial endocarditis or urinary tract
infections. In pyelonephritis induced · by non-hemolytic Group
B strains, on the contrary, sulfonamide therapy would be indi
cated. Without recognizing the essential relationship of these
non-hemolytic strains to the serological Groups B and D, respec
tively, the clinician might easily mistake both for S. viridans and
apply the same treatment to both.
Drug Fast Strains. . The failure of Group D strains to respond
to sulfonamide therapy (9, 34) raises the question of how many
Group A. strains may also have a natural or acquired resistance
to these drugs. Apparently, increasing numbers of resistant
Group A. strains are being encountered. One wonders, therefore,
whether in addition to these naturally drug resistant strains,
other Group A. streptococci may not acquire fastness to the drug
and thus lead to a wide dissemination of strains resistant to these
chemotherapeutic agel).ts.
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Characteristics of Group'. Polysaccharides. Although the car
bohydrates characteristic of each of the eleven serological groups
are convenient tags for identification, the function of these so- ,
called C substances in the streptococcal cell is not understood.
There is no group agglutination corresponding to the group pre
cipitin reaction, and the variations in non-type-specific agglu
tination do not appear to be correlated with the amount of
group-specific C antibody present in the serum.
The group-specific carbohydrate, however, in the streptococcal
cell seems remarkably constant in amount and apparently does
not vary with changes in virulence and in other functions. Since
washing the streptococci yields only traces of the group-specific
polysaccharide and since cellular disruption is required to obtain
it in any quantity, it seems likely that this substance is not pres
ent as a capsule but rather forms an integral part of the bacterial
cell.
The group-specific carbohydrate of Group A organisms has
been studied more than the polysaccharides characteristic of
other groups. It is not toxic for animals, and is antigenic only
when still in combination with the cellular protein (55). On
hydrolysis, this substance yields reducing sugars and according
to unpublished results of Sherp ( quoted by Heidelberger and
Kendall (55)) contains an amino sugar. The precipitin test with
this polysaccharide provides a simple method for group identifi
cation and differentiation of potential pathogens for a given
animal species, but it is obvious that associated biochemical and
cultural functions are important in the metabolism and physi
ology of these bacteria.
EXTRACELLULAR SUBSTANCES ELABORATED BY STREPTOCOCCI

Although the separation of substances elaborated by micro
organisms into extracellular and intracellular components is a
somewhat artificial distinction, it is useful in contrasting the
toxic constituents due to active growth of the streptococcus with
those found only after disintegration of the bacterial cells.
Streptolysins. We have already considered the extracellular
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toxin which is responsible for the hemolytic properties of strep
tococci, namely, the streptolysin, or, rath�r, the two streptolysins,
- which Todd has shown are characteristic of Group A. Todd ( 129)
studied also the streptolysins produced by strains representative
of other groups and -found the oxygen-labile streptolysin O in
culture filtrates of certain Group C and Group G strains (Table
IV), as well as in those of all Group A strains, but the oxygen
stable streptolysin � is quite specific for Group A. Other strepTABLE IV
. Streptolysins of Group A and Other Groups
Streptolysins eharaeteristic
of Group A
Streptolysin

Streptolysin

Other streptolysins

A .......................................

Present

Present

............

C (Matt eolony)

Present

............

G (Matt eolony)

Present

............

All other groups

............

............

Serologieal
group

0

s

P,...,,t but littl,
} studied

tolysins, not yet identified either as to number or kind, are ob
viously present in other serological groups of hemolytic strepto
cocci, as indicated in the last column of Table IV. Although
serological identification of these streptolysins has not yet proved
feasible,. because antibodies have not been obtained for thexp.,
Todd has shown that several may be distinguished by their strik
ing differences in susceptibility to the influence of oxygen, of
heat and of acid (Table V). Further study may result in the
discovery of methods suitable for antibody production specifically
directed against these other streptolysins.
Erythrogenic Toxins. In a few laboratories, the capacity of
members of the various serological groups to produce erythro
genic toxins has been determined. These toxins are responsibie
for the rash in scarlet fever and are formed by most Group A

.,,,..-

-

TABLE V
Characteristics of Streptolysins of Different Groups*

Effect on streptolysins of

Serological group
A, Streptolysin O ........................ ...............
A, Streptolysin S ............... ............ ... .......
B

........................................ ................ ........................

C, ("Human °) Streptolysin O ...
C, (''Animal'')

·Oxygen

Heat

Reversibly
inactivated

Destroyed

-

Antistreptolysin 0

Destroyed

Destroyed

Antistreptolysin S

Moderately
sensitive

Moderately
sensitive

Destroyed

-

-

Reversibly
inactivated

-

Destroyed

D

......................... ................... .....................................

-

-

E

.....................................................................................

-

Destroyed

G, (large colony) Streptolysin 0

Streptolysin
neutralized
by

Reversibly
inactivated

* Compiled from Todd's data (129, 132).
- indicates unaffected.

Destroyed

Acid

Slightly
sensitive

-

Antistreptolysin 0

-

Destroyed·

-

-

.A.ntistreptolysin 0

-

�
t,,j
�
0
�
�
8
H
a
00
8
�
"O
8
0
a
0
a
a
H

�

0:,
o;)

Colony

G:Poup C
'Animal" �t:Paine "Human'' .et:Pain6
(A1Po eome

animal .stPains)

Mucoid

AfteP dPying:
- Matt

.

Matt

. ..
�

5ma11 smooth
Fm. 1.

Fo.P.rne

G:Poup G
Human .5tr>aine
Human

and
anima1 .5t�ain.5

"Minute"

Matt

FIG. 1.
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strains, but not usually by members of other groups (17, 22, 23,
. 68, 105).
Ftbrinolysin. Another extracellular -component of hemolytic
streptococci is the fibrinolysin discovered by Tillett and Garner
( 125). This substance is capable of dissolving the clot of normal
human blood, and appears to be enzymatic in nature; but the
products of lysis differ from those obtained when fibrin is di
gested by trypsin. Among the many investigations stimulated
by the discovery of fibrinolysin are those relating this. phenom
enon to particular groups of hemolytic streptoco�ci. The sero
logic�l groups which form fibrinolysin are the following: Group
A, almost without exception; and the la.rge matt colony Group
C and Group G strains.
Jn order to show other relationships of the streptococci of dif
ferent groups which produce fibrinolysin it may be of interest at
this p-oint to discuss the different forms of Group C and Group G
strains. Some members of these two groups are linked together
by several common characteristics; others from wiq.ely divergent
sources have little in common except their respective group-spe
cific polysaccharides. In each group, several decidedly different
colony forms occur. In Group C, some of the strains widely dis
tributed among lower animals form large mucoid colonies, asso
ciated with capsules (Fig. 1), or, if the mucoid substance is
absent, they form small smooth colonies. On drying, the colony
surface changes. from mucoid to matt.
Other Group C strains fo:r-m large matt colonies which charac
terize the strains of human, monkey· and canine origin and also.
some of the strains causing equine diseases other than strangles.
They are also characteristic of the non-hemolytic Group C strains
from bovine mastitis and joint-ill of lambs.
Streptococci of Group G form either minute or large colonies.
The former, described by Long and Bliss (87), is a pin point
colony with a large area of hemolysis; the latter is a large matt
colony indistinguishable morphologically, from the matt colonies
of Group C, and incidentally of Group A (Fig. 2).
Group C and Group G strains which form matt colonies are
\
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Colony Fo.Pm5
Matt colonies

G:Pou-p A

G:0ou-p C

•.
.,,,,
..
o o
\

··-· 0

.,,

__ __

}'10. 2.

also similar in their fermentation reactions with trehal ose and
sorbitol (Table VI). Both produce the extracellular substances,
fibrinolysin and streptolysin O. In these and in other respects,
they also resemble Group A to such an extent that they can only
be distinguished serologically. 'fhey show their close relationship
to each other in that they possess a common protein antigen, but
this is not encountered in Group A strains. This antigen some-

TABLE VI

N)
m
00

Distingitishing Characteristics of Gro11ps C a1ul G
Group C
''Animal''*
Colony form

Mucoid or
small smooth

Hemolytic zone

Wide

Capsule.

+ (mucoid)
- (small)

Fermentation: Trehalose
Sorbitol
Fibriuolysin
Streptolysiu O (Group A) .
Common protein antigen
Animal distribution:
llfan
Monkey
Horse
Cow
Sheep
Dog
Most other lowe1· animals

+

-

T

+

+

+
+

* T,rpe A of Ogura alld Eclw:irds, 97, %, :27.

I

Group G
"Hmn:m "t

Large Colony

'':Minute''
(Type 1)

Large matt

Large matt

Minute, smooth

Moderate

Moderate

+

+

-r

+

-

-

+

+

+

+
+
+
+
+

+
+
+
+

t Types 131 and B:l uf Ogurn alld Edwards.

·wide

-

+
+

:::0

trj
to
trj
0
0
p,0
ts

t>-·

z

0
trj

ts
tJ
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times gives rise to confusing cross reactions between certain
members of Groups C .and G. 'l'he cross relationship, however, is
not connected ·with the group-specific polysaccharides of these
l\rn groups since their respective polysaccharides when free of
this protein are serologically distinct.
Antisera may be prepared free of cross reactions by ab ·orption
with appropriate matt-colony Group C or Group G strains or by
immunizing rabbits with strains which do not contain this par
ticular protein antigen. Examples of the latter are strains of
guinea pig origin in Group C and "minute" colony strains in
Group G, but certain technical difficulties sometimes interfere
with their use as antigen. for group antisera.
Hyaluronic Acid. The last extracellular product of hemolytic
streptococci to be considered is the capsular substance, hyaluronic
acid, formed by mucoid strains of Groups A and C. Kendall,
Heidelberger and Dawson (64) isolated this substance from
mucoid Group A l1emolytic streptococci and identified it as an
acid polysaccharide of high molecular weight composed of acetyl
glucosamine and glucuronic acid in equimolar concentrations.
It £unctions neither as an antigen nor as a hapten, possibly
because it is also normally present in the tissues of animals used
for immunization. Sources other than bacterial from which
hyaluronic acid has been isolated include bovine vitreous humor,
fowl .·arcoma, pig skin, Wharton's jelly of human umbilical cord,
.·,vnovial fluid and the pleural fluid of a patient with meso
thelioma.
Seastone (109) studied a similar non-antigenic mucoicl poly
saccharide from Group C hemolytic streptococci of animal origin.
While it has been suggested (86) that the mucoid capsular sub
stance of hemolytic streptococci is related to their virulence,
this has not been established-in the case of Group A. Seastone,
on the other band, has demonstrated that the variants of Group C
which were highly virulent for guinea pigs produced much larger
eapsules and much more polysaccharide than did strains of low
virulence. The different relationship to virulence of this cap
sular substance in Groups A and C respectively, has been clearly
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demonstrated by Hirst (57) who showed that the bacterial cells
of both groups were decapsulated in vivo, as well as in vitro, by
leech extract. The decapsulation apparently protected both mice
aud guinea pigs from fatal infection with Group C streptococci,
but wa. ineffective in mice inoculated with virulent Group A
strains. This suggests that sub ·tances other than the mucoid
polysaccharide are related to virulence of organisms of the latter
group. Purther evidence indicates that in Group A, the type
specific protein, M, is associated with virulence, and that immune
serum containing antibodies specifically directed ag·ainst this
substance protects mice against infection with virulent strains
of homologous type.
TYPE RELATIONSHIPS

So far, this discussion has dealt primarily ·with the relationship
between the various cellular constituents and the corresponding
biological activities of streptococci in terms of their serological
grouping. Let us now examine the specific types so far differ
entiated within these groups to see what definite activities can
be associated with them or with their determinative antigenic
components.
Serological '.l.'yves in Gronv A. In 1919 (25), we established
the principle that type differentiation of epidemic strains could
be effected by serolog·ical methods. Subsequent studies on the
type-specific substances have definitely supported this conceptioii.
In 1926 (40), Griffith attempted by slide agglutination to
eliminate one of the great difficulties inherent in all agglutination
techniques w.ith streptococci, namely, the difficulty of obtaining
stable suspensions. His method also reduced the time and mate
rial required for tests. He first established four types, and in
1927, determined that seventy per cent of 222 scarlatina) strains
fell into these four recognized types (41). Subsequentl_v, he
continued his serological classification all(l in 1934, published
epidemiological studies in which 27 types of hemolytic strepto
cocci were defined ( 43). 'l'wenty-three of these types were later
found to be members of Group A, while the other four types
fell into other serological groups: Types 7, 20 and 21 into Group
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C, and Type 16 into Group G. Griffith's type classification of
Group A hemolytic streptococci has been universally adopted.
Although most of the scarlatina[ strains of hemol:vtic strepto
cocci are included within these types, Griffith and other investi
gators have found that not all strains isolated from streptococcal
infections or from carriers fall into these recognized t)'pes. In
deed, Griffith has recently added three more; and other investi
gators .have also described still other types, some of which appear
to be more prevalent during certain yea.rs and in certain localities.
Griffith pointed out that the methods employed by him, i.e.,
direct ag·glutinatiou combined with agglutinin absorption,. re
vealed the dominant antigen which determines type specificity,
but he did not attempt to analyze more clo ely the whole antigenic
structure. Investigation of this latter problem has been one of
the chief interests in our laboratory; and studies in this direc
tion have brought to light the fa.ct that at lea.st two type-specific
antigenic components are concerned with the type-specific reac
tions of Group A hemolytic streptococci. These components have
l
been designated M and '' (81).
Relation of the 1'ype-specific Protein, M, to Colony Forrn. The
type-specific protein, M, is the antigen primarily associated with
virulence; and the antibodies to which it gives rise are primarily
concerned with the specific protective action of immune sera..
It is present only in those variants which form mucoid or matt
colonies (Fig. 3). Mucoid, matt and glossy variants are the
forms ordinarily observed (126), but Dawson (24) has also ob
tained a more degraded "rough" form, corresponding to the
rough variants in a generalized scheme for all bacteria. The
mucoid variant possesses the same antigens as the matt variants
and, in addition, produces the serologically inactive capsular
substance, hyaluronic acid (64). _The matt form may be either
virulent or non-virul.ent, but in either state, matt variants con
tain approximately equal amounts of the type-specific M sub
stance (83, 134). The glossy forms are always a.virulent and
contain little or no M substance. They sometimes form mucoid
colonies. Immunization of animals with virulent or avirulent
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matt variants induces the formation of anti-M precipitins and
protective antibodies. Immunization of animals with the gloss�·

Colony Fo.Pms
G:0oup A

Mucoid

Matt

Glo.esy

0

9
FIG. 3.

form fails to induce either protective antibodies or anti-M
precipitins.
Relation of the M Snbstance to Type-specific Reactions. In its
relation to the pathogenic properties of the streptococcus, tbe M
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substance appears to fm1ction in a manner somewhat parallel to
that of the type-specific capsular polysaccharide of Pneumo
coccus. It reacts well in the precipitin test with t�·pe-specific
antisera, and by this mea11s a serolog'icall.,· distinct .-nbstance
can be demonstrated for each individual t�rpe. 'rhe lVI antibod�·
produced by animals in response to immunization with intact
living or dead streptococci or with sol.utions of the M substance
extl'acted from them appears responsible for t?pe-specific pro
tection. In most types, the M antibody causes agglutination of'
lVI-containing 01·ganisms of the same type . In at least one type,
however (Type 1), M antibody fails to bring about agglutination
in spite of the fact that both M antigen aud its antibody are
present in the system and can be demonstrated by the precipitin
reaction and by passive protection tests (81).
'!'here is, at present, no explanation for th is failure of the M
antibody to cause a0·glntination of 'l'ype 1 organism. when all
conditions seem favorable for the reactiou. It is well-recognized
that occasional strains belonging to various types ma.,· at times
be refractory to agglutination but this inagglutinability is not
comparable to the phenomenon described here, since Type 1
streptococci invariably fail to be agglutinated by M antibod�·.
That the suspensions are agglutinable in the presence of an appro
priate ahtibody is shown wben they are brought into contact "·ith
serum containing a second type-specific antibody directed against
the recently discovered, so-called, 'l'' substance. Prompt and
striking type-specific agglutination then occurs.

Relation of the Type-specific Snbstance, T, to 1-lgglntinati· o11.

'l'he most important type-specific agyl·ntinoge11 iu all t,q)es of
Group A appears to be the T substance. Although a.ntibocl.,· to
this substance apparently .has no protective action, it is probabl�r
the principal antibody respousible for t,q)e-classification based
upon the agglutination reaction. This bl'ings up the interesting
question oft.he functioning of two type-specific substances in 01ie
microorganism. Unless M and 'I' are definitely correlated, one
could imagine many possible types clue to man�� different anti
genic corn binations.
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CorrelaMon of JIil. ancl T Antigens in Incliviclnal Types. For
tunately, while the number of types is indeed imposing, it is not
often complicated by a lack of correspondence between the M
and T antigens. Because the T antigen was unknown in 1934,
when Griffith's report on twenty-three types of Group A hemo
lytic streptococci appeared, it was former]�, thought that the same
type-specific antibody was responsible for the M precipitin reac
tion and for the agglutination reactions, which GL"iffith was
studying. N·evertheless, representative strains and sera2 of Dr.
Griffith's types were tested to make sure that this was true. For
lack of suitable anti-M sera, not quite aJl types could be tested,
but the few minor differences in. results of type-determinations
based on the M precipitin reaction or on the slide agglutination
technique were easily reconciled with the sing·le exception of
Strain C203, a Group A strepto_coccus widely used for experi
mental work. l<'or several years, it was a puzzle to understand
why this strain appeared to be Type 1, as Dr. Griffith ( 43) classi
fied it, b�, its agg-Jutination reactions, and yet by the M precipitin
reactions and mouse protection tests, studied in this laborator�·,
it reacted as Type 3. It finally became clear that this was due
to an extra T substance not normally present in 'l'ype 3 strepto
cocci. Thus, Strain C203 ha. both the Mand T antigens of Type
3, and an additional T antigen of Trpe l. The latter is the
dominant antigen effective in the agglutination reactions of this
strain ( 81).
From preliminanr study, it seems probable that some such
unusual association of antigens exists in certain othel' types which
are l1ard to differentiate by their agglutination reactions. This
seems true in the case of Types 17 and 23 (66, 69, 99), which some
authors have thought identical. Their M substances are, how
ever, as distinct as those of any other type , but some strains
of these two types undoubtedly have a complex of 'l' antigens
not yet completely differentiated.
Another factor, complicating the analysis of irnmnnologica l
reactions of streptococci, is that the bacterial cells contain a
2 Thc�c were gcHCJ"Ousl�- snppliecl by Dr. Griffith.
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mixture of nucleoproteins which are usually not type-specific,
nor even species-specific in their serological reactions. Thus, in
the precipitin reaction and also in active and passive anaphylaxis,
these cellular components show marked cross relationships (72,
74-76). Reactions with them do not appear with all immune sera
and all extracts. Rabbits vary in their response to immunization
with whole. streptococci, sometimes producing these so-called
P-antibodies and sometimes failing to produce them. It has also
been found that M extracts which usually give type-specific reac
tions may contain variable amounts of the nucleoprotein mixture,
P. For these reasons, one must constantly be on the alert to avoid
misinterpretation of results. Although it is not clear whether
the P-anti-P systems are concerned in cross agglutinations, this
possibility should always be borne in mind.
Characteristics of the Type-specific.Protein, M. Before the dis
covery of the T substance, the protein, M, was subjected to careful
study both of a serological and a chemical nature. This substance
is obtained relatively free of other cellular proteins by extracting
the streptococci with acid and heat, a procedure which renders
most proteins insoluble; but the type-specific protein, M, is
brought into solution by this treatment. 'l'he M substance floccu
lates near pH 4.2, and is precipitated from neutral solution by
the addition of alcohol. It belongs, however, to the class of
alcohol soluble proteins (38), exhibiting a number of chemical
properties in common with these substances: for example, in the
form of the hydrochloride, the M substance is soluble in 80
per cent alcohol. Another interesting peculiarity is the great
rapidity with which the M substance is digested by trypsin and
pepsin.
In spite of its protein nature, this substance first appeared to
be a hapten, which was capable of giving in vitro reactions. It
did, nevertheless, induce an·aphylactic shock in guinea pigs
passively sensitized with anti-M immune serum prepared against·
whole streptococci. At that time, however, it was not found
antigenic when injected into rabbits and mice, nor did it actively
sensitize guinea pigs.
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Recently, the work of Stamp and Hendry (123), and that of
Mudd and his associates (93, 140) has indicated that the M
substance in more gently treated preparations might be a true
antigen. Dr. Hirst and I (58) also found that under better con
ditions of extraction, the M substance is antigenic; and even in
the form originally prepared and thought non-antigenic (73,
74, 76), it was subsequently found to exhibit a certain degree of
antigenicity if larger doses were injected. When isolated. from
the cell, this substance is, however, a much poorer antigen than
are the intact cells from which it was derived.
Proteolytic Digestion of the Type-specific M Substance from
· the Living Cell. Because proteolytic enzymes digest the type
specific protein, M, in solutions, the effect of enzymes on living
hemolytic streptococci has been studied. Following Allison's
suggestion, several investigators have treated streptococci with
trypsin in order to transform granular, spontaneouly agglutinat
ing cultures into diffuse, stable suspensions suitable for slide
agglutination reactions (66). It was observed, however, both
here and elsewhere ( 65), that these diffuse suspensions became
at the same time very susceptible to agglutination with sera
known to contain streptococcus agglutinins of a non-type-specific
nature. This seemed analogous to the change occurring in a given
strain of streptococcus when the matt form is degraded to the
glossy by the loss of its type-specific protein, M (83, 134). This
possibility was tested by trying to extract the M substance with
hydrochloric acid from matt organisms which had been subjected
to digestion with trypsin, or to obtain it from· cultures grown in
a medium containing active trypsin. It was found that the M
substance could no longer be isolated from streptococci which
had been treated in either of these ways with trypsin. The fol
lowing facts were also observed : (1) The bacteria were not killed
by digestion. Plate counts of suitable dilutions of the trypsin- ·
treated and control cultures showed no significant difference in
the number of organisms in each. (2) 3Trypsin-treated strepto
cocci were just as virulent for mice as the control cultures, appars Some of these experiments were caried out by Dr. G. K. Hirst.
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ently because the function of producing the M protein had not
been affected. Consequently, when the first growth occurred in
the peritoneal cavity, this protein was again produced. (3) 3 Bac
teria, heat-killed immediately after treatment with trypsin, failed
to induce the formation of M antibody when injected into rab
bits, although the controls did so uniformly. (4) Other proteo
lytic enzymes were also able to digest M substance from the living
bacteria in the same way. These experiments will be reported in
full at another time. From this evidence, one must conclude
that the M substance in the living bacteria is readily accessible
to the action of proteolytic enzymes without injury to other vital
functions of the living cells. This may be due to its possible loca
tion near the outer surface of the streptococci.
The Type-specific Substance, T, of Group A Streptococci. In
vestigation of the chemical nature and immunological activity
of the second type-specific component of Group A hemolytic
streptococci has been greatly hampered by the failure so far to
recover it from the bacterial cell bodies in a form suitable for
study.

Pathogenicity of Members of Different Types in Group A.

Many investigators, studying the specific types of Group A hemo
lytic streptococci in different diseases, have found a lack of corre
lation between any particular types and the diseases in which
they are found. Thus, scarlet fever, erysipelas, puerperal sepsis
and other streptococcal infections may all be caused by the same
types, or by different types at different times. Allison (1) stated
in 1938, that the first four serological types included upwards of
50 per cent of all cases of scarlet fever occurring in London over
a period of ten years. In Australia, on the other hand, a differ
ent series of types has predominated and these were not the same
in Sydney, Melbourne or Adela�de (66). In 1931H>, in New York,
Pauli and Coburn (99) found Types 4, 13 and 22 most common
in throats of rheumatic fever patients; while Kuttner and Krum
weide (70), in another group of rheumatic fever patients near
New York in 1937-40, found still other types predominant in
different years. Strains isolated from rheumatic fever and other
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patients in the Rockefeller Hospital have likewise varied greatly
from year to year. There is, apparently, no fixed relationship
between the virulence of a type in one epidemic or locality and
its effect at another time and place; and all gradations in severity
of clinical manifestations may result from a single type in any
one epidemic. Consequently, it does not seem possible that the
type-specific substances, M and T, equally present on different
occasions could be responsble for the divergent clinical effects,
but rather that other unknown fluctuating factors affecting viru
lence must be operative in both host and parasite.
It has been demonstrated that the secondary complications in
scarlet fever are often due to types different from those respon
sible for the primary attacks (2, 14, 136, 137). These secondary
complications apparently arise from cross infection in wards
containing patients carrying many different types. It is, there
fore, indicated that, when individual isolation is impossible,
patients placed in a single ward should be restricted to those
carrying the same serological type of hemolytic streptococcus.
When this has been done, the number of secondary streptococcal
complications has been materially reduced. Hare's recent work
on the carrier problem also lends weight to these observations
( 48-51).
Serological Types in Group B. The existence of specific types
in Group B was first established by Stableforth (121) in England,
who found three serological types among strains from bovine
mastitis which were sharply defined by their precipitin and
agglutinin reactions. Reasoning by analogy with the type
specific protein of Group A, he assumed that the type-specific
substance in Group B was also a protein. It has developed from
studies in our laboratory (78, 80), however, that the type-specific
-substances in this group are polysaccharides. We also differ
entiated four specific types on the basis of precipitin reactions
with type-specific polysaccharides obtained respectively from
each individual type, and different from the group-specific carbo
hydrate C. Sufficiently detailed chemical studies were made of
the type-specific substances from two of these types to indicate
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that they were polysaccharides. In the other less well-studied
types, preliminary investigation indicated that polysaccharides
were also responsible for type-specificity.
Correlation of antibodies against these polysaccharides with
type-specific immunity was shown in the protection afforded mice
infected with Types Ia or lb, if the respective antisera were ad
ministered, and in the lack of such protection in the presence of
antisera.of heterologous Group B types. The importance of these
polysaccharides in virulence was also shown by a million-fold
decrease in mouse virulence when virulent microorganisms were
so treated that they no longer elaborated type-specific poly
saccharides. On immunization with these degraded cultures,
type-specific precipitins and protective antibodies were not
formed; but precipitin for the group-specific polysaccharide, C,
was formed much more readily than usual and in greater amount.
These observations indicate that type-specific polysaccharides
have a direct relationship to the antigenic properties of Group B
streptococci, and in many instances appear to have an association
with their pathogenicity.
English and Australian investigators (94, 117, 122, 124) have
been particularly active in epidemiological studies involving the
further differentiation of Group B types, but have not identified
the antigens involved. Employing a slide agglutination tech
nique, they have distinguished about fourteen main and subtypes
among bovine strains, and five more types which included 86 out
of 100 strains of human origin. Since only one of these 100
human strains fell into a bovine type, Simmons and Keogh (117)
concluded that types of Group B streptococci indigenous to man
and cattle are quite distinct and that human carriers are not,
therefore, usually a source of infection in cattle. Brown (12,
13) and also Little (84) in this country, however, have indicated
that the human carrier should be considered in attempts to eradi-.
cate bovine mastitis. My own study of a limited number of
strains would indicate a somewhat greater frequency of the same
specific types from human and bovine sources than that found by
Simmons and Keogh (see Table VII). The difference in opinion
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may possibly be due to the different methods used for identifying
strains. Further study of this question is needed.
TABLE VII
Serological Types of Group B Streptococci Identified by Precipitin R·eaction

Source
Human
Non-pathogenic
......................................
Associated with disease
Etiological agent of disease*
Total human
Bovine
Milk and mastitis
Reported by Plastridge and Hartsell (102)
Total bovine

....

Number in Types
Ia

lb

II

III

3
1

6

14
3
1

8
1
3

20
2

10

18

12

28

5

9

11

28

33

1
10

6

9

9

4

20

13

* Includes strains from some of the fatal infections recorded in Table III.

Serological Types in Other Groups: Some progress has been
made in several laboratories in distinguishing types within the
other known groups.
Group C. The :first serological types differentiated in Group C
were the Types 7, 20, and 21 of Griffith's 1934 classification of S.
pyogenes (43). These types are composed of large matt colony
Group C strains that are probably similar culturally to the Types
Bl and B2 of animal origin classi:fied by Ogura by means of fer
mentation and other biochemical reactions. By .using the fer
mentation of trehalose and sorbitol as differential tests, P. R.
Edwards (28, 29), following the work of Ogura (97), has done·
much toward clarifying the differences between these so-called
"human" Group C strains and the chief "animal" Group C
strains (Type A Ogura). One would like to know how much con
nection there is between types determined by biochemical reac
tions and those based upon serological reactions. Evans has
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pointed out relationships between certain series of serological
types in Group A and susceptibility to the action of different
races of bacteriophage which she has studied. Australian inves
tigators also have _concluded that definite correlation occurs be
tween biochemical and serological reactions, at least in Groups
A, C and G (65).
The latter investigators have attempted to classify into sero
logical types the Group C strains encountered in their studies:
on the one hand, strains chiefly from the human throat, and on
the other, strains from equine infections. Using slide agglutina
tions, Simmons and Keogh found five main types among human
throat strains; and Bazeley and Battle ( 5) found five main
equine serological types which were in close agreement with the
biochemical types, corresponding also to the biochemical types
described previously by Ogura. Serological subtypes have been
found, but not completely studied as yet within the main equine
types. Most of these types have not been tested by means of the
precipitin reaction.
Study of type-specific substances among Group C strains has
not progressed very far. From at least one of the Group C types
identified by Griffith (Type 21), I have, in preliminary experi
ments, obtained a type-specific substance which was digested by
trypsin. No similar substance could be obtained from the mucoid
animal strains (Type A, Ogura), although Stamp and Hendry
(123) protected mice against infection with such a strain by
immunizing them with a protein fraction obtained in extracts.
A type-specific substance was recently found in Group C strains
of one specific. type which caused nine separate out-breaks of
suppurative arthritis in lambs in East Anglia, England (7).
From extracts of these streptococci, a type-specific protein was
separated from the group-specific polysaccharide, C. Lambs
which recovered were immune and their blood contained a spe
cific bactericidal substance. A further interesting feature· was
the demonstration that these Group C streptococci were the
methemoglobin producing, or alpha type, similar to the alpha
Group C strains from bovine mastitis. The authors draw atten-
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tion to the similarity of the streptococci from joint-ill to these
bovine strains and to the Group C strains of human origin. With
none of the other human or animal Group C strains at their dis
posal were they able to induce joint-ill in lambs but none were
of the same serological type as those from joint-ill.
Groups F and G. Both the precipitin and slide agglutination
techniques have been applied by Bliss (8) with equal success to
the differentiation of serological types among the "minute"
hemolytic streptococci of Groups F and G. In Group F, two
large and well-defined types have been found, and a third smaller
and less distinct type seemed to be present. The ''minute''
strains belonging to Group G form one serological type, with a
type-specific antigen which is so similar serologically to that of
the Type 1, Group F, strains, as to suggest that these antigens
may be identical chemically.
As already implied, these Type 1 strains of Groups F and G
differ sharply in their group-specific antigens, the "C" poly
saccharides, which are entirely characteristic of their respective
groups (77). Serological relationships of this sort, based on
chemical similarity of the antigens concerned, are not uncommon
among bacteria, or even among apparently unrelated forms of
life.
Simmons and Keogh (117), using slide agglutinations only,
have investigated the serological types of 78 Group G strains of
human origin isolated in Australia, and have found evidence of
more than one type in the "minute" strains studied by them,
and of three types among the large colony strains.

Miscellaneous Information Concerning Types in Various
Groups. In our own laboratory, some evidence of the occurrence
of specific types based on the precipitin reaction has been encoun
tered among other groups as follows: Group D, 3 distinct types;
Group E, 1; Group F, 2; Group G, 1; Group K, 1. Strains un
classified as to type remain in all groups. Houston and his col
laborators have also indicated the finding of specific types among
the enterococci (Group D) although the details have not, I think,
been published (39, 61, 62).
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In none of the types enumerated among groups other than A
and B has the type-specific substance been isolated and studied
except in crude extracts. Their behavior, however, suggests that
the type-specific antigens in all except Groups A and C, are prob
ably polysaccharides, but further study of these substances is
needed to determine their chemical nature.
Overlapping Immunological Relationships. Overlapping im
munological reactions have been observed with increasing fre
quency not only among bacteria but also in other natural sources
widely separated generically. Although such cross reactions usu
ally indicate genetic relationships, it also sometimes happens that
no consistent relationship is apparent. However, where chemical
data are available, it has been found that serological similarities
are always based on chemical likenesses, whether the determina
tive substances are derived from related or unrelated sources.
Examples of this phenomenon are fairly common among hemo
lytic streptococci, and these cases suggest genetic relationships.
These overlapping reactions are comprehensible because related
chemical components have been isolated from the streptococci in
several of these instances. Frequently, the overlapping speci
ficity appears dependent on chemical relationships between type
specific polysaccharides, as between two types in Group B (78,
80). Another example occurs between two types, one of which is
in Group F, the other in Group G (8). More obscure cross rela
tionships, not always reciprocal, have been observed. These in
clude agglutinations of certain Group B and C strains in sera of
certain Group A types. Finally, some of the cross agglutinations
in Group A which were formerly confusing are now understood
because of knowledge concerning the T substance.
Summary of Group and Type Siibstances. In order to leave
with you a clear conception of t�e Group and Type antigens so
far known, I· have prepared a table showing somewhat arbi
trarily the simpler relationships of these substances. The first
and second columns indicate that each group has an individual
polysaccbaride, the C substance, specific for that group. The
last three columns show the substances concerned with type-speci-
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TABLE VIII
Group and Type Specific Antigens of Hemolytic Streptococci
Type specificity

Group specificity
Serological
group

Group specific
'' C'' substances

A

B
C
Remaining
groups

Polysaccharides immunologically distinct for
each group

Specific types
recognized

Type specific substances
Designated

At least 30

"M"

Several
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Several

No symbol

Several

"8"
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Chemical nature
Proteins
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Proteins
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fl.city within each group and what is known of their chemical
nature. Thus, in each of the 30 odd types of Group A strepto
cocci, an individual type-specific protein, M, is associated with
virulence; and the antibodies to which this type-specific sub
stance gives rise are responsible for the serological and protec
tive action of immune sera. The second type-specific substance,
T, in Group A, is known chiefly as an agglutinogen, usually one
T substance for each type; its chemical nature is not yet deter
mined. In Group B, the type-specific substance of each indi
vidual type is a polysaccharide, designated S, and appears to be
solely responsible for type-specificity. In at least one type within
Group C, a protein is the type-specific substance, and proteins
also appear to be the type-specific substances in two other types
within this group. In mucoid strains of this group, the non
antigenic mucoid polysaccharide plays an important part in viru
lence, but is not apparently associated with type-specificity.
In other groups, less is known about the type-specific sub
stances, but the evidence suggests that polysaccharides are
chiefly concerned.
SUMMARY

In summarizing the results of these immunochemical studies
of hemolytic streptococci, one might question the wisdom of dis
secting the microorganism so completely rather than studying its
functions as a whole. In complicated systems where the inter
actions between bacteria and host are being investigated, much
information can be obtained by studying the various components
separately.
At present, the biological function of the group-specific poly
saccharide C is not understood. Although we are unaware of
how this substance contributes to the metabolism of the bacterial
cell, it is useful as a meani, of identifying the origin of the par
ticular streptococcus from which it was derived. In this way,
strains pathogenic for man can be distinguished from those which
are of animal origin and only rarely, if ever, induce disease in
human beings. Other related characteristics can also be sur
mised by identifying this particular cell component.
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The function of the type-specific substance is better understood
than is that of the group-specific polysaccharides. It seems cer
tain that the type-specific protein, M, is related to the virulence�
of Group A streptococci; and the host's reaction in producing
antibodies against the M substance is one of the important means
of protection against infection with these cocci. The type-specific
activities of Group A strains are chiefly referable to the M pro
tein, except that type-specific agglutination is now known to be
related primarily to another cellular component of unknown
chemical composition, the T substance. Antibodies engendered
by this substance apparently do not exert any protective action
in combatting infection. Whether the M and T substances exist
in combined or separate form in the cell is still to be determined;
but the presence of T substance, both in matt variants and their
avirulent glossy derivatives, explains why Group A hemolytic
streptococci may lose their type-specific M protein and still ex
hibit type-specific agglutination. Before the T component of the
type-specific complex was known, it was difficult to explain the
type-specific agglutination of strains producing little, if any, M
protein. Even though not all of the immunological reactions of
hemolytic streptococci are understood, the general pattern has
become much clearer since this part of it has been elucidated.
The examples mentioned indicate the direction of these studies
of hemolytic streptococci and emphasize the relationship of spe
cific cellular components to the biological activities of the whole
microorganism.
BIBLIOGRAPHY

Allison, V. D., Lancet, 1938, 1, 1067.
Allison, V. D., and Brown, W. A., J. Hyg., 1937, 87, 11.
Barnard, W. G., and Todd, E. W., J. Path. and Bact., 1940, 51, 43.
Bazeley, P. L., Austral. Vet. J., 1940, 16, 187, 243.
Bazeley, P. L., and Battle, J., Austral. Vet. J., 1940, 16, 140.
Besredka, A., Ann. Inst. Pasteur, 1901, 15, 880.
Blakemore, F., Elliott, S. D., aud Ha1·t-Mercer, J., J. Path. and Bact.,
°1941, 52, 57.
8. Bliss, E. A., J. Bact., 1937, 33, 625.
9. Bliss, E. A., and Long, P. H., New Eng. J. Med., 1937, 217, 18.
10. Boisvert, P. L., J. Bact., 1940, 39, 727.
1.
2.
3.
4.
5.
6.
7.

HEMOLYTIC STREPTOCOCCI

287

11. Brown, J. H., Monographs of the Rock. Inst. for Med. Res., 1919, No.
9, New York.
12. Brown, J. H., Cornell Vet., 1937, 27, 110.
13. Brown, J. H., J. Bact., 1939, 37, 133.
14. Brown, W. .A.., and Allison, V. D., J. Hyg., 1935, 35, 283; 1937, :n, 1.
15. Cannon, A. B., Sanders, M., and Rankin, J. L., Arch. Dermatol. and
Syphilol., 1940, 42, 884.
16. Coburn, .A.. F., and Pauli, R. H., J. Ezp. Med., 1935, 62, 129, 137, 159;
1941, 73, 551.
17. Coffey, J.M., J. Imm1tnol., 1938, 36, 121.
18. Colebrook, D. C., Med. Res. Coun. Spec. Rep., No. 205, London, H. M.
Stationery Office, 1935.
19. Colebrook, L., and Purdie, A. W., Lancet, 1937, 2, 1237, 1291.
20. Congdon, P.M., Lancet, 1935, 2, 1287.
21. Cumming, W.M., J. Path. and Bact., 1927, 30, 279.
22. Davis, L. J., and Guzdar, J. S., J. Hyg., 1935, 36, 161.
23. Davis, L. J., and Guzdar, J. S., J. Path. and Bact., 1936, 43, 197.
. 24. Dawson,M. H., Hobby, G. L., and Olmstead, M., J. Inf. Dis., 1938, 62,
138.
25. Dochez, A. R., Avery, 0. T., and Lancefield, R. C., J. Ezp. Med., 1919,
30, 179.
26. Edwards, P. R., J. Bact., 1932, 23, 259.
27. Edwards, P. R., J. Bact., 1933, 26, 527.
28. Edwards, P. R., J. Bact., 1934, 27, 527.
29. Edwards, P. R., Kent1wlcy A.gri. Ezp. Sta. Bull., Mar., 1935, No. 356,
p. 3.
30. Edwards, S. J., J. Comp. Path. and Therap., 1932, 45, 43.
31. Elser, W. J., and Thomas, R. A., J. Bact., 1936, 31, 79.
32. Evans, A. C., Pub. Health Rep., U. S. P. H. S., 1934, 49, 1386.
33. Evans, A. C., J. Bact., 1940, 40, 215.
34. Francis, A. E., Brit. Med. J., 1941, 1, 288.
35. Fry, R.M., J. Path. and Bact., 1933, 37, 337.
36. Fry, R.M., Lancet, 1938, 1, 199.
37. Gay, F. P., J. Lab. and Olin. Med., 1918, 3, 721.
38. Goadby, K., Proc. Roy. Soc., London, 1927-8, 102, 137.
39. Graham, N. C., and Bartley, E. O., J. Hyg., 1939, 39, 538.
40. Griffith, F., J. Hyg., 1926, 25, 385.
41. Griffith, F., J. Hyg., 1927, 26, 363. ·
42. Griffith, F., J. Hyg., 1928, 27, 113.
43. Griffith, F., J. Hyg., 1934, 34, 542.
44. Gunnison, J. B., Luxen, M. P., Cummings, J. R., and Marshall, M. S.,
J. Bact., 1940, 39, 689.
45. Gunnison, J. B., Lu."\'.en, M. P., Marshall, M. S., and Engle, B. Q., J.
Dairy Sci., 1940, 23, 447.

288
46.
47.
48.
49.
50.
51.
52.
53.
54.

REBECCA C. LANCEFIELD
Hare, R., J. Path. and Bact., 1935, 41, 499.
Hare, R., J. Path. and Bact., 1937, 44, 71.
Hare, R., Canad. Pub. Health J., 1937, 28, 1.
Hare, R., Canad. Pub. Health J., 1940, 31, 407.
Hare, R., Canad. Pub. Health J., 1940, 31, 539.
Hare, R., Lancet, 1940, 1, 109.
Hare, R., and Maxted,W. R., J. Path. and Bact., 1935, 41, 513.
Hare, T., and Fry, R. M., Vet. Rec., 1938, 50, 213.
Heidelberger, M., and Avery, 0. T., J. Exp. Med., 1923, 38, 73; 1924,
40, 301.

Heidelberger, M., and Kendall, F. E., J. Immunol., 1936, 30, 267.
Hill, A. M., and Butler, H. M., Med. J. .Austral., 1940, 1, 222, 293.
Hirst, G. K., J. Exp. Med., 1941, 73, 493.
Hirst, G. K., and Lancefield, R. C., J. Exp. Med., 1939, 69, 425.
Hitchcock, C. H., J. Exp. Med., 1924, 40, 445.
Hitchcock, C. H., J. Exp. Med., 1924, 40, 575.
Houston, T., Ulster Med. J., 1934, 3, 224.
Houston, T., Second Internat. Cong. for Microbiology, London, 1936,
Rep. of Proc., 141.
63. Keefer, C. S., and Spink,W.W., J. Clin. Invest., 1937, 16, 155.
64. Kendall, F. E., Heidelberger, M., and Dawson, M. H., J. Biol. Chem.,

55.
56.
57.
58.
59.
60.
61.
62.

1937, 118, 61.
65. Keogh, E. V., and Simmons, R. T., J. Path. and Bact., 1940, 50, 137.
66. Keogh, E. V., Simmons, R. T., andWilson, H., Aust. J. Exp. Biol. and
Med. Sci., 1941, 19, 51.
67. Kobayashi, R., Dept. of Bacteriology, Medical College, Keio-Gijuku
University, Tokyo, 1939.
68. Kodama, T., Kitasato Arch. Exp. Med., 1936, 13, lQl, 217.
69. Kodama, T., Ozaki, M., Nishiyama, S., and Chiku, Y., Kitasato .Aroh.
Exp. Med., 1938, 15, 162.
70. Kuttner, A. G., and Krumweide, E., J. Clin. Invest., 1941, 20, 273.
71. Lancefield, R. C., J. Exp. Med., 1925, 42, 377.
72. Lancefield, R. C., J. Exp. Med., 1925, 42, 397.
73. Lancefield, R. C., J. Exp. Med., 1928, 47, 91.
74. Lancefield, R. C., J. Exp. Med., 1928, 47, 469.
75. Lancefield, R. C., J. Exp. Med., 1928, 47, 843.
76.. Lancefield, R. C., J. Exp. Med., 1928, 47, 857.
7-J. Lancefield, R. C., J. Exp. Med., 1933, 67, 571.
78. Lancefield, R. C., J. Exp. Med., 1934, 59, 441.
79. Lancefield, R. C., J. Exp. Med., 1934, 59, 459.
80. Lancefield, R. C., J. Exp. Med., 1938, 67, 25.
81. Lancefield, R. C., J. Exp. Med., 1940, 71, 521, 539.
82. Lancefield, R. C., and Hare, R., J. Exp. Med., 1935, 61, 335.
83. Lancefield, R. C., and Todd, E.W., J. Exp. Med., 1928, 48, 769.

HEMOLYTIC STREPTOCOCCI

289

84.
85.
86.
87.
88.
89.
90.
91.
92.
93.
94.

Little, R. B., J. Exp. Med., 1938, 68, 905.
Little, R. B., Proc. Soc. Exp. Biol. and Med., 1939, 41, 254.
Loewenthal, H., Brit. J. Exp. Path., 1938, 19, 143.
Long, P.H., and Bliss, E.A., J. Exp. Med., 1934, 60, 619.
Mandelbaum,M., Z. Hyg. u. Infections"kran"kh., 1907-8, 68, 26.
MacCallum, W. G., andHastings, T. W., J. Exp. Med., 1899, 4, 521.
Macdonald, I., Med. J. Aust., 1939, 2, 471.
McLeod, J. W., J. Path. and Bact., 1911-12, 16, 321; 1914-15, 19, 392.
Miller, W. T., andHeishman, J. O., Cornell Vet., 1940, 30, 310.
Mudd, S., and Lackman, D. B., J. Immunol., 1940, 39, 495.
Murnane, D., Commonwealth of Australia, Bull. No. 134, Melbourne,

95.
96.
97.
98.

Neill, J.M., andMallory, T. B., J. Exp. Med., 1926, 44, 241.
Neter, E., and Young, G. S., A1n. J. Dis. Children, 1937, 63, 1531.
Ogura, K., J. Jap. Soc. Vet. Sci., 1929, 8, 174.
Pasteur, L., Bull. de l 'Acad. de Med., 1879, 8, 256, in Oeuvres de
Pasteur, P. Vallery Radot, 1933, 6, 131.
Pauli, R. H., and Coburn,A. F., J. Exp. Med., 1937, 66, 595.
Pilot, I., Buck, C., and Davis, D. J., Proc. Soc. Exp. Biol. and Med.,
1936, 34, 233.
Pilot, I., Buck, C., Davis, D. J., and Eastman, D. A., Proc. Soc. Exp.
Biol. and Med., 1936, 34, 499.
Plastridge, W. N., andHartsell, S. E., J. Inf. Dis., 1937, 61, 110.
Plummer, H., J. Bact., 1934, 27, 465.
Plummer,H., J. Bact., 1935, 30, 5.
Pomales-Lebr6n, A., Puerto Rico J. Pub. Health � Trop. Med., 1940,
16, 66.
Rantz, L.A., and Keefer, C. S., J. Inf. Dis., 1941, 68, 128.
Schottmiiller, H., ./l{unch. Med. Woch., 1903, 1, 849.
Seastone, C. V., J. Bact., 1934, 28, 481.
Seastone, C. V., J. Exp. Med., 1939, 70, 347, 361.
Seegal, B. C.,Heller, G., and Jablonowitz, J., Proc. Soc. Exp. Biol. and
Med., 1936, 34, 812.
Sherman, J.M., Bact. Rev., 1937, 1, 1.
Sherman, J.M., J. Bact., 1938, 36, 81.
Sherman, J.M., and Niven, C. F., J. Inf. Dis., 1938, 62, 190.
Sherman, J. M., Smiley, K. L., and Niven, C. F., J. Dairy Sci., 1940,

1940.

99.
100.
101.
102.
103.
104.
105.
106.
107.
108.
109.
110.
111.
112.
113.
114.

23, 529.
115. Sherman, J.M., and Stark, P., J. Dairy Sci., 1934, 17, 525.
116. Sherman, J.M., Stark, P., andMauer, J. C., J. Bact., 1937, 33, 483.
117. Simmons, R. T., and Keogh, E. V., Austral. J. Exp. Biol. and Med.
Sci., 1940, 18, 151.
118. Smith, F. R., Niven, C. F., and Sherman, J.M., J. Bact., 1938, 36, 425.

290

REBECCA C. LANCEFIELD

· 119. Smith, T., and Brown, J. H., J. Med. Research, 1914-15, 31, N.S. 26,
455.
120. Smythe, C. V., and Harris, T. N., J. Immunol., 1940, 38, 283.
121. Stableforth, A. W., J. Comp. Path. and Therap., 1932, 45, 185.
122. Stableforth, A.W., J. Path. and Bact., 1937, 45, 263.
123. Stamp, T. C., and Hendry, E. B., Lancet, 1937, 1, 257.
124. Stewart, D. F., J. Path. and Bact., 1937, 45, 279.
125. Tillett, W. S., Bact. Rev., 1938, 2, 161.
126. Todd, E.W., Brit. J. Exp. Path., 1928, 9, 1.
127. Todd, E.W., J. Exp. Med., 1928, 48, 493.
128. Todd, E.W., J. Exp. Med., 1932, 55, 267.
129. Todd, E.W., J. Path. t Bact., 1934, 39, 299.
130. Todd, E.W., Brit. J. Exp. Path., 1938, 19, 367.
131. Todd, E.W., J. Path. f Bact., 1938, 47, 423.
132. Todd, E.W., J. Hyg., 1939, 39, 1.
133. Todd, E.W., Coburn, A. F., and Hill, A. B., Lancet, 1939, 2, 1213.
134. Todd, E.W., and Lancefield, R. C., J. Exp. Med., 1928, 48, 751.
135. Torrey, J. C., and Montu, E., J. Inf. Diseases, 1934, 55, 340.
136. deWaal, H. L., J. Hyg., 1940, 40, 172.
137. de Waal, H. L., J. Hyg., 1941, 41, 65.
138. Weld, J. T., J. Exp. Med., 1934, 59, 83.
139. Weld, J. T., J. Exp. Med., 1935, 61, 473.
140. Zittle, C. A., J. Immunol., 1939, 37, 1.

